Article Information
History
- June 3, 2020.
Article Versions
- You are currently viewing Version 1 of this article (June 3, 2020 - 16:06).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Martin Neukam1,2,3,
- Katharina Ganß1,2,3,
- Jovana Vasiljević1,2,3,
- Johannes Broichhagen4,5,
- Kai Johnsson4,
- Thomas Kurth6 and
- Michele Solimena1,2,3,7,#
- 1Molecular Diabetology, University Hospital and Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany
- 2Paul Langerhans Institute Dresden (PLID) of the Helmholtz Center Munich at the University Hospital Carl Gustav Carus and Faculty of Medicine of the TU Dresden, Dresden, Germany
- 3German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany
- 4Max-Planck-Institute for Medical Research, Department of Chemical Biology, Heidelberg, Germany
- 5Forschungsinstitut für Molekulare Pharmakologie, Department of Chemical Biology, Berlin, Germany
- 6TU Dresden, Center for Molecular and Cellular Bioengineering (CMCB), Technology Platform, Dresden, Germany
- 7Max Planck Institute for Molecular Cell Biology and Genetics, Dresden, Germany
- ↵#Corresponding author. Tel.: +49-351-796-366-11, e-mail: Michele.Solimena{at}uniklinikum-dresden.de